Pregnancy-induced hypertension (PIH) is a relatively frequent disease in nulliparous, socioeconomically deprived black women seen in inner-city medical centers. Although the etiology of PIH may be multifactorial, when compared to control pregnancies, enhanced maternal vascular reactivity is a consistent finding. Further, increased utero-placental vascular resistance appears to be a good predictor, and perhaps an important factor for the development of pre-eclampsia. Enhanced vascular reactivity may be related to alterations in circulating vasodilators/pressors or, more likely, to changes in intrinsic myogenic tone. In the past several years it has become increasingly clear that hypertensive states with enhanced vascular reactivities are associated with altered states of cellular cation metabolism. Indeed, abnormal cellular cation metabolism, particularly decreased cation transport, is generally seen in the black hypertensive population. Clinicians and researchers alike have long recognized the importance of early non-invasive diagnosis of PIH and a better understanding of the physiological process behind the changes seen. Through our proposal, we hope to gain insight into both of these areas. In our proposed studies we will characterize gestational age-specific changes in cellular cation metabolism, circulating mediators of cation transport and peripheral vascular resistance in nulliparous black women, ages 15 to 25 years. We are particularly interested in the relationship between alterations in intracellular divalent cations (calcium and magnesium) and changes in maternal and umbilical vascular reactivity. Calcium, magnesium, sodium and potassium concentrations, and calcium, magnesium and sodium/potassium transport activity will be evaluated in maternal erythrocytes and platelets, fetal erythrocytes, umbilical artery smooth muscle cells, and placental membrane preparations. We hope to determine if alterations in cellular cation levels precede as well as related to he development of PIH and accompanying maternal-fetal complications. If this is indeed the case, it will offer the possibility of a relatively non-invasive early predictor for risk of pre-eclampsia.

Project Start
1988-03-01
Project End
1991-02-28
Budget Start
1989-03-01
Budget End
1990-02-28
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Hamaty, M; Guzman, C B; Walsh, M F et al. (2000) High glucose-enhanced acetylcholine stimulated CGMP masks impaired vascular reactivity in tail arteries from short-term hyperglycemic rats. Int J Exp Diabetes Res 1:69-79
Ali, S S; Igwe, R C; Walsh, M F et al. (1999) Troglitazone and vascular reactivity: role of glucose and calcium. Metabolism 48:125-30
Goalstone, M L; Natarajan, R; Standley, P R et al. (1998) Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology 139:4067-72
Song, J; Walsh, M F; Igwe, R et al. (1997) Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production. Diabetes 46:659-64
Sowers, J R (1997) Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 29:691-9
Sowers, J R (1997) Effects of calcium antagonists on insulin sensitivity and other metabolic parameters. Am J Cardiol 79:24-8; discussion 47-8
Skafar, D F; Xu, R; Morales, J et al. (1997) Clinical review 91: Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab 82:3913-8
Sowers, J R; Sowers, P S; Peuler, J D (1994) Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 123:647-52
Zhang, F; Ram, J L; Standley, P R et al. (1994) 17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 266:C975-80
Zhang, F; Sowers, J R; Ram, J L et al. (1994) Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 24:170-5

Showing the most recent 10 out of 17 publications